Cargando…

Aberrant glycosylation in colorectal cancer with genomic and epigenomic alterations

Detalles Bibliográficos
Autores principales:	Okayama, Hirokazu, Noda, Masaru, Kono, Koji
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2018
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6235014/ https://www.ncbi.nlm.nih.gov/pubmed/30479691 http://dx.doi.org/10.18632/oncotarget.26292

Ejemplares similares

The role of KRT17 in colorectal cancer
por: Ujiie, Daisuke, et al.
Publicado: (2021)

Hotspots of aberrant enhancer activity punctuate the colorectal cancer epigenome
por: Cohen, Andrea J., et al.
Publicado: (2017)

Drug resistance related to aberrant glycosylation in colorectal cancer
por: Very, Ninon, et al.
Publicado: (2017)

Aberrant O‐glycosylation contributes to tumorigenesis in human colorectal cancer
por: Jiang, Yuliang, et al.
Publicado: (2018)

PD-L1 overexpression in EBV-positive gastric cancer is caused by unique genomic or epigenomic mechanisms
por: Nakano, Hiroshi, et al.
Publicado: (2021)

Genomic and epigenomic alterations in prostate cancer
por: Aschelter, Anna M., et al.
Publicado: (2012)

The co-evolution of the genome and epigenome in colorectal cancer
por: Heide, Timon, et al.
Publicado: (2022)

Involvement of Aberrant Glycosylation in Thyroid Cancer
por: Miyoshi, Eiji, et al.
Publicado: (2010)

Epigenetic Bases of Aberrant Glycosylation in Cancer
por: Dall’Olio, Fabio, et al.
Publicado: (2017)

Prognostic role of FUT8 expression in relation to p53 status in stage II and III colorectal cancer
por: Noda, Masaru, et al.
Publicado: (2018)

Aberrant glycosylation associated with enzymes as cancer biomarkers
por: Meany, Danni L, et al.
Publicado: (2011)

Epigenomic landscape of human colorectal cancer unveils an aberrant core of pan-cancer enhancers orchestrated by YAP/TAZ
por: Della Chiara, Giulia, et al.
Publicado: (2021)

Translation of genomics and epigenomics in prostate cancer: progress and promising directions
por: Liu, Wennuan, et al.
Publicado: (2016)

The allure of the epigenome
por: Attar, Naomi
Publicado: (2012)

Environmental Epigenomes
por: Perera, Bambarendage P. U., et al.
Publicado: (2023)

In silico deconvolution and purification of cancer epigenomes
por: Duran-Ferrer, Martí, et al.
Publicado: (2017)

Aberrant transcriptional regulations in cancers: genome, transcriptome and epigenome analysis of lung adenocarcinoma cell lines
por: Suzuki, Ayako, et al.
Publicado: (2014)

Role of aberrant glycosylation enzymes in oral cancer progression
por: Vajaria, Bhairavi N., et al.
Publicado: (2018)

Aberrant Glycosylation as Biomarker for Cancer: Focus on CD43
por: Tuccillo, Franca Maria, et al.
Publicado: (2014)

Link between Epigenomic Alterations and Genome-Wide Aberrant Transcriptional Response to Allergen in Dendritic Cells Conveying Maternal Asthma Risk
por: Mikhaylova, Lyudmila, et al.
Publicado: (2013)

Warning Signs From the Crypt: Aberrant Protein Glycosylation Marks Opportunities for Early Colorectal Cancer Detection
por: Chandrasekar, Dharini, et al.
Publicado: (2023)

Immunogenic tumor cell death induced by chemotherapy in patients with breast cancer and esophageal squamous cell carcinoma
por: Aoto, Keita, et al.
Publicado: (2018)

Recent Advances in Understanding the Role of Genomic and Epigenomic Factors in Noncommunicable Diseases
por: Shekhar, Hossain U., et al.
Publicado: (2019)

Microanatomy of inferior mesenteric artery sheath in colorectal cancer surgery
por: Sakamoto, Wataru, et al.
Publicado: (2019)

Direct analysis of aberrant glycosylation on haptoglobin in patients with gastric cancer
por: Kim, Jae-Han, et al.
Publicado: (2016)

Targeting oral cancer epigenome via LSD1
por: Bais, Manish V.
Publicado: (2017)

Aberrant O-glycosylation modulates aggressiveness in neuroblastoma
por: Cuello, Hector A., et al.
Publicado: (2018)

The sex chromosomes of the aging epigenome
por: Tan, Qihua
Publicado: (2020)

Acknowledgment to Reviewers of Epigenomes in 2021
Publicado: (2022)

Acknowledgement to Reviewers of Epigenomes in 2018
Publicado: (2019)

Acknowledgment to Reviewers of Epigenomes in 2020
Publicado: (2021)

Acknowledgment to the Reviewers of Epigenomes in 2022
Publicado: (2023)

Epigenomic analysis detects aberrant super-enhancer DNA methylation in human cancer
por: Heyn, Holger, et al.
Publicado: (2016)

Protein N-glycosylation aberrations and glycoproteomic network alterations in osteoarthritis and osteoarthritis with type 2 diabetes
por: Luo, Yi, et al.
Publicado: (2022)

Integrative glycoproteomics reveals protein N-glycosylation aberrations and glycoproteomic network alterations in Alzheimer’s disease
por: Zhang, Qi, et al.
Publicado: (2020)

Identification of diagnostic markers in colorectal cancer via integrative epigenomics and genomics data
por: KOK-SIN, TEOW, et al.
Publicado: (2015)

The Epigenomics of Embryonic Pathway Signaling in Colorectal Cancer
por: Balch, Curt, et al.
Publicado: (2017)

Non-mutational (epigenomic) structural variation in the transcriptome of cancer cells
por: Thompson, E. Aubrey
Publicado: (2015)

Updates on “Cancer Genomics and Epigenomics”
por: Sharma, Aarti, et al.
Publicado: (2020)

Altering cancer transcriptomes using epigenomic inhibitors
por: Gaddis, Malaina, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_60qnv4g87gp85mvvnotod5niv0